Singleron Biotechnologies
Singleron | End-to-End Single Cell Sequencing Solution
Nanjing, China · Founded 2018 · $140.0M raised
- Headquarters
- Nanjing
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2B
- Website
- singleron.bio
- Total Funding
- $140.0M
- Last Round
- $100.0M Series BNov 2021
- Rounds
- 4
About
Single-cell multi-omics solutions company advancing precision medicine with end-to-end sequencing platforms.
Summary
Singleron Biotechnologies is a Biotech company based in Nanjing, China, founded in 2018. It has raised $140.0M in total across 4 rounds, most recently a $100.0M Series B round in Nov 2021. Investors include Lilly Asia Ventures, Lake Bleu Capital and Firstred Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company